Participate in a Study

SCCA was formed, in part, to bring promising new treatments to patients faster. For pancreas cancer patients this means more treatment options at SCCA than might be found elsewhere, including participation in one of many ongoing clinical trials conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.

Not all patients are cured with standard therapy, and some standard treatments may have more side effects than are desired; therefore, patients may seek help through a clinical trial. Patients who participate in clinical trials have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease.

Researchers are currently looking at new chemotherapy drugs and are studying combinations of chemotherapy drugs with radiation therapy. Research is also under way to evaluate pancreas cancer vaccines intended to stimulate the patient's immune system. Patients whose disease has spread can use many of these procedures.

 

Pancreas Cancer Clinical Trials at Fred Hutchinson Cancer Research Center.